218 related articles for article (PubMed ID: 14576453)
1. The nature of dominant mutations of rhodopsin and implications for gene therapy.
Wilson JH; Wensel TG
Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
[TBL] [Abstract][Full Text] [Related]
2. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
3. Stable rhodopsin/arrestin complex leads to retinal degeneration in a transgenic mouse model of autosomal dominant retinitis pigmentosa.
Chen J; Shi G; Concepcion FA; Xie G; Oprian D; Chen J
J Neurosci; 2006 Nov; 26(46):11929-37. PubMed ID: 17108167
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.
Mendes HF; van der Spuy J; Chapple JP; Cheetham ME
Trends Mol Med; 2005 Apr; 11(4):177-85. PubMed ID: 15823756
[TBL] [Abstract][Full Text] [Related]
5. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
[TBL] [Abstract][Full Text] [Related]
6. Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype.
Han Z; Banworth MJ; Makkia R; Conley SM; Al-Ubaidi MR; Cooper MJ; Naash MI
FASEB J; 2015 Jun; 29(6):2535-44. PubMed ID: 25713057
[TBL] [Abstract][Full Text] [Related]
7. Gene delivery of wild-type rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa mouse model.
Mao H; Gorbatyuk MS; Hauswirth WW; Lewin AS
Adv Exp Med Biol; 2012; 723():199-205. PubMed ID: 22183334
[TBL] [Abstract][Full Text] [Related]
8. Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa.
Sudharsan R; Beltran WA
Adv Exp Med Biol; 2019; 1185():113-118. PubMed ID: 31884598
[TBL] [Abstract][Full Text] [Related]
9. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
Mitra RN; Zheng M; Weiss ER; Han Z
Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
[TBL] [Abstract][Full Text] [Related]
11. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa.
Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM
EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285
[TBL] [Abstract][Full Text] [Related]
12. A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.
Rosenfeld PJ; Cowley GS; McGee TL; Sandberg MA; Berson EL; Dryja TP
Nat Genet; 1992 Jun; 1(3):209-13. PubMed ID: 1303237
[TBL] [Abstract][Full Text] [Related]
13. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
Dryja TP; McGee TL; Hahn LB; Cowley GS; Olsson JE; Reichel E; Sandberg MA; Berson EL
N Engl J Med; 1990 Nov; 323(19):1302-7. PubMed ID: 2215617
[TBL] [Abstract][Full Text] [Related]
14. Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration.
Colley NJ; Cassill JA; Baker EK; Zuker CS
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3070-4. PubMed ID: 7708777
[TBL] [Abstract][Full Text] [Related]
15. The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.
Athanasiou D; Aguila M; Bellingham J; Li W; McCulley C; Reeves PJ; Cheetham ME
Prog Retin Eye Res; 2018 Jan; 62():1-23. PubMed ID: 29042326
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller B; Mao H; Lewin AS
Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
[TBL] [Abstract][Full Text] [Related]
17. Silencing gene therapy for mutant membrane, secretory, and lipid proteins in retinitis pigmentosa (RP).
Shinohara T; Mulhern ML; Madson CJ
Med Hypotheses; 2008; 70(2):378-80. PubMed ID: 17590524
[TBL] [Abstract][Full Text] [Related]
18. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.
Lewin AS; Drenser KA; Hauswirth WW; Nishikawa S; Yasumura D; Flannery JG; LaVail MM
Nat Med; 1998 Aug; 4(8):967-71. PubMed ID: 9701253
[TBL] [Abstract][Full Text] [Related]
19. Retinopathy induced in mice by targeted disruption of the rhodopsin gene.
Humphries MM; Rancourt D; Farrar GJ; Kenna P; Hazel M; Bush RA; Sieving PA; Sheils DM; McNally N; Creighton P; Erven A; Boros A; Gulya K; Capecchi MR; Humphries P
Nat Genet; 1997 Feb; 15(2):216-9. PubMed ID: 9020854
[TBL] [Abstract][Full Text] [Related]
20. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model.
Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A
Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
